| Thomas G Reid, CRNA | |
|
61 Charles St, Deadwood, SD 57732-1303 | |
| (605) 722-6101 | |
| (605) 719-6133 |
| Full Name | Thomas G Reid |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 28 Years |
| Location | 61 Charles St, Deadwood, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811935299 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R024270 (South Dakota) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | CR000391 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Monument Health Spearfish Hospital | Spearfish, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Monument Health Network Inc | 5991616427 | 143 |
News Archive
Oraya Therapeutics Inc. announced that full results of three-year safety follow-up data from the INTREPID study of Oraya Therapy™ for wet age-related macular degeneration (AMD) further demonstrated a favorable safety profile and also showed that there was no significant difference in vision outcomes in patients treated with Oraya Therapy compared with those receiving anti-vascular endothelial growth factor (anti-VEGF) injections alone.
Facet Biotech Corporation and Bristol-Myers Squibb Company announced that potentially promising data from a Phase I/II study of elotuzumab, an investigational humanized antibody being studied for the treatment of relapsed multiple myeloma (MM), were presented today at the American Society of Hematology (ASH) 2009 Annual Meeting in New Orleans.
The most rigorous genetic sequencing ever carried out on a single tumor reveals far greater genetic diversity among cancer cells than anticipated. Researchers from the University of Chicago and the Beijing Institute of Genomics estimate that the tumor, about 3.5 centimeters in diameter, contained more than 100 million distinct mutations within the coding regions of its genes—thousands of times more than expected.
At the American Chemical Society (ACS)Spring 2012 National Meeting & Expo (Booth #218), PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will be showcasing new chemistry-focused informatics solutions and technologies, including the Reaction Genius software platform for better chemistry knowledge sharing and workflow productivity.
Half the residents of New Orleans were suffering from poor mental and physical health more than a year after their homes and community were devastated by Hurricane Katrina in August 2005, according to research published in the September issue of the UK-based Journal of Clinical Nursing.
› Verified 5 days ago
| Entity Name | Monument Health Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588185268 PECOS PAC ID: 5991616427 Enrollment ID: O20031111000854 |
News Archive
Oraya Therapeutics Inc. announced that full results of three-year safety follow-up data from the INTREPID study of Oraya Therapy™ for wet age-related macular degeneration (AMD) further demonstrated a favorable safety profile and also showed that there was no significant difference in vision outcomes in patients treated with Oraya Therapy compared with those receiving anti-vascular endothelial growth factor (anti-VEGF) injections alone.
Facet Biotech Corporation and Bristol-Myers Squibb Company announced that potentially promising data from a Phase I/II study of elotuzumab, an investigational humanized antibody being studied for the treatment of relapsed multiple myeloma (MM), were presented today at the American Society of Hematology (ASH) 2009 Annual Meeting in New Orleans.
The most rigorous genetic sequencing ever carried out on a single tumor reveals far greater genetic diversity among cancer cells than anticipated. Researchers from the University of Chicago and the Beijing Institute of Genomics estimate that the tumor, about 3.5 centimeters in diameter, contained more than 100 million distinct mutations within the coding regions of its genes—thousands of times more than expected.
At the American Chemical Society (ACS)Spring 2012 National Meeting & Expo (Booth #218), PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will be showcasing new chemistry-focused informatics solutions and technologies, including the Reaction Genius software platform for better chemistry knowledge sharing and workflow productivity.
Half the residents of New Orleans were suffering from poor mental and physical health more than a year after their homes and community were devastated by Hurricane Katrina in August 2005, according to research published in the September issue of the UK-based Journal of Clinical Nursing.
› Verified 5 days ago
| Entity Name | Monument Health Rapid City Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275553463 PECOS PAC ID: 6002729506 Enrollment ID: O20070625000144 |
News Archive
Oraya Therapeutics Inc. announced that full results of three-year safety follow-up data from the INTREPID study of Oraya Therapy™ for wet age-related macular degeneration (AMD) further demonstrated a favorable safety profile and also showed that there was no significant difference in vision outcomes in patients treated with Oraya Therapy compared with those receiving anti-vascular endothelial growth factor (anti-VEGF) injections alone.
Facet Biotech Corporation and Bristol-Myers Squibb Company announced that potentially promising data from a Phase I/II study of elotuzumab, an investigational humanized antibody being studied for the treatment of relapsed multiple myeloma (MM), were presented today at the American Society of Hematology (ASH) 2009 Annual Meeting in New Orleans.
The most rigorous genetic sequencing ever carried out on a single tumor reveals far greater genetic diversity among cancer cells than anticipated. Researchers from the University of Chicago and the Beijing Institute of Genomics estimate that the tumor, about 3.5 centimeters in diameter, contained more than 100 million distinct mutations within the coding regions of its genes—thousands of times more than expected.
At the American Chemical Society (ACS)Spring 2012 National Meeting & Expo (Booth #218), PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will be showcasing new chemistry-focused informatics solutions and technologies, including the Reaction Genius software platform for better chemistry knowledge sharing and workflow productivity.
Half the residents of New Orleans were suffering from poor mental and physical health more than a year after their homes and community were devastated by Hurricane Katrina in August 2005, according to research published in the September issue of the UK-based Journal of Clinical Nursing.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas G Reid, CRNA 353 Fairmont Blvd, Atten Mss, Rapid City, SD 57701-7375 Ph: () - | Thomas G Reid, CRNA 61 Charles St, Deadwood, SD 57732-1303 Ph: (605) 722-6101 |
News Archive
Oraya Therapeutics Inc. announced that full results of three-year safety follow-up data from the INTREPID study of Oraya Therapy™ for wet age-related macular degeneration (AMD) further demonstrated a favorable safety profile and also showed that there was no significant difference in vision outcomes in patients treated with Oraya Therapy compared with those receiving anti-vascular endothelial growth factor (anti-VEGF) injections alone.
Facet Biotech Corporation and Bristol-Myers Squibb Company announced that potentially promising data from a Phase I/II study of elotuzumab, an investigational humanized antibody being studied for the treatment of relapsed multiple myeloma (MM), were presented today at the American Society of Hematology (ASH) 2009 Annual Meeting in New Orleans.
The most rigorous genetic sequencing ever carried out on a single tumor reveals far greater genetic diversity among cancer cells than anticipated. Researchers from the University of Chicago and the Beijing Institute of Genomics estimate that the tumor, about 3.5 centimeters in diameter, contained more than 100 million distinct mutations within the coding regions of its genes—thousands of times more than expected.
At the American Chemical Society (ACS)Spring 2012 National Meeting & Expo (Booth #218), PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will be showcasing new chemistry-focused informatics solutions and technologies, including the Reaction Genius software platform for better chemistry knowledge sharing and workflow productivity.
Half the residents of New Orleans were suffering from poor mental and physical health more than a year after their homes and community were devastated by Hurricane Katrina in August 2005, according to research published in the September issue of the UK-based Journal of Clinical Nursing.
› Verified 5 days ago
Elizabeth K Groeger, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 61 Charles St, Deadwood, SD 57732 Phone: 605-722-6101 | |
Terry Lloyd Keszler, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 61 Charles St, Deadwood, SD 57732 Phone: 605-722-6101 |